Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ishita Drugs And IndustriesBOM:524400 +1.00%74 Pretax Margin % is 9.13% as of Mar. 2026, which is 41% above its 10-year median of 6.48. GuruFocus rates BOM:524400 with a GF Score™ of 74/100 and a GF Value™ of ₹78.36 (Fairly Valued). The stock has 3 warning signs investors should review. Among 959 Drug Manufacturers companies, Ishita Drugs And Industries ranks better than 50.16% on this metric.
The historical rank and industry rank for Ishita Drugs And Industries's Pretax Margin % or its related term are showing as below:
BOM:524400'
s Pretax Margin % Range Over the Past 10 Years
Min: 4.4 Med: 6.48 Max: 7.7
Current: 7.37
BOM:524400's Pretax Margin % is ranked better than 50.16% of 959
companies
in the Drug Manufacturers industry
Industry Median: 7.29
vs BOM:524400: 7.37
Ishita Drugs And Industries (BOM:524400) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Ishita Drugs And Industries Pretax Margin % Related Terms
Ishita Drugs And Industries Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524400 vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ishita Drugs And Industries Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Ishita Drugs And Industries's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ishita Drugs And Industries (BOM:524400) has a Pretax Margin % of 9.13% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ishita Drugs And Industries and its competitors. This is 41% above median its historical median of 6.48. Over the past decade, Ishita Drugs And Industries' Pretax Margin % has ranged from 4.40 to 7.70. According to the industry distribution chart, Ishita Drugs And Industries ranks #478 out of 959 companies in the Drug Manufacturers industry, placing it in the top 49.8%.
Is Ishita Drugs And Industries' Pretax Margin % too high?
Ishita Drugs And Industries' current Pretax Margin % of 9.13% is 41% above median its 10-year median of 6.48. Over the past 10 years, this metric has ranged from a low of 4.40 to a high of 7.70. The Drug Manufacturers industry median Pretax Margin % is 7.29. Ishita Drugs And Industries' value of 9.13% is 25.2% above this industry median. Based on the distribution chart, Ishita Drugs And Industries ranks #478 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ishita Drugs And Industries has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ishita Drugs And Industries ranks #478 out of 959 companies for Pretax Margin %. This puts Ishita Drugs And Industries in the upper half of its industry. The industry median Pretax Margin % is 7.29. Ishita Drugs And Industries' value of 9.13% is 25.2% above this benchmark. Historically, Ishita Drugs And Industries' own Pretax Margin % has ranged from 4.40 to 7.70 over the past decade. While the company's 10-year median is 6.48 vs. the industry median of 7.29, Ishita Drugs And Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ishita Drugs And Industries's current Pretax Margin % of 9.13% is 25.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ishita Drugs And Industries and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ishita Drugs And Industries's current Pretax Margin % is 9.13%, which is 41% above median its own 10-year median of 6.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.36, compared to a current price of ₹71.79 — trading 8.4% below its estimated fair value. The current Pretax Margin % is 9.13%, which is 41% above median its 10-year median of 6.48 and 25.2% above the Drug Manufacturers industry median of 7.29. Ishita Drugs And Industries' overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current Pretax Margin % is 9.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?
Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued.
The current stock price of ₹71.79 is trading 8.4% below its estimated GF Value™ of ₹78.36.
GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.
Key valuation signals for BOM:524400:
Pretax Margin %: 9.13% (41% above median its 10-year median of 6.48)
GF Value™: ₹78.36 vs. price of ₹71.79 (8.4% below fair value)
Industry Position: 25.2% above the Drug Manufacturers median (#478 of 959)
No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
74GF Score
Get the complete analysis for BOM:524400
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524400 has been successfully added to your 
